Abstract
A synergistic combination of electroporation and electrolysis (SEE) has been found with distinct advantages over tissue ablation by electrolysis or electroporation alone. Minimally invasive tissue ablation by electrolysis uses a low magnitude direct electric current to produce a lesion due to the creation of chemical products that result in cell death. Electroporation creates permeabilizations in the cell membrane which may lead to loss of cell homeostasis and cell death. When these two modes of tissue ablation are combined, a more effective method of cell death is achieved, likely due to the ability of electrolytic products to access the cell interior through the permeabilized cell membrane. Here, a new method of achieving SEE tissue ablation is obtained through the application of a single exponential decay pulse. This parametric study explores the mechanisms of damage as a function of the initial electric field and amount of delivered charge. It is seen that treatment parameters can dictate the mode of tissue ablation, either by SEE or by irreversible electroporation alone.
Similar content being viewed by others
References
Amory, R. A Treatise on Electrolysis and its Therapeutical and Surgical Treatement in Disease. New York: William Woof & Co., 1886.
Choi, Y. S., et al. Preclinical analysis of irreversible electroporation on rat liver tissues using a microfabricated electroporator. Tissue Eng. Part C. 16(2):1245–1253, 2010.
Colombo, L., G. Gonzalez, G. Marshall, F. V. Molina, A. Soba, C. Suarez, et al. Ion transport in tumors under electrochemical treatment: in vivo, in vitro and in silico modeling. Bioelectrochemistry. 71(2):223–232, 2007.
Czymek, R., D. Dinter, S. Loeffler, M. Gebhard, T. Laubert, A. Lubienski, et al. Electrochemical treatment: an investigation of dose–response relationships using an isolated liver perfusion model. Saudi J. Gastroenterol. 17(5):335–342, 2011.
Czymek, R., J. Nassrallah, M. Gebhard, A. Schmidt, S. Limmer, M. Kleemann, et al. Intrahepatic radiofrequency ablation versus electrochemical treatment in vivo. Surg. Oncol.-Oxford. 21(2):79–86, 2012.
Davalos, R. V., L. M. Mir, and B. Rubinsky. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 33(2):223–231, 2005.
Davalos, R.V. and Rubinsky, B., inventors; The Regents of the University of California, assignee. Tissue ablation with irreversible electroporation. USA 2004.
Edd, J., L. Horowitz, R. V. Davalos, L. M. Mir, and B. Rubinsky. In-vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans. Biomed. Eng. 53(5):1409–1415, 2006.
Gravante, G., S. L. Ong, M. S. Metcalfe, N. Bhardwaj, G. J. Maddern, D. M. Lloyd, and A. R. Dennison. Experimental applications of electrolysis in the treatment of liver and pancreatic tumours: principles, preclinical and clinical observations and future perspectives. Surg. Oncol. 20:106–120, 2011.
Miklavcic, D., A. Fajgelj, and G. Sersa. Tumor treatement by direct electric-current-electrode material deposition. Bioelectrochem. Bioenerg. 35(1–2):93–97, 1994.
Miklavcic, D., T. Jarm, M. Cemazar, G. Sersa, D. J. An, J. Belehradek, et al. Tumor treatment by direct electric current. Tumor perfusion changes. Bioelectrochem. Bioenerg. 43(2):253–256, 1997.
Miklavcic, D., L. M. Mir, and P. T. Vernier. Introduction to third special electroporation-based technologies and treatments issue. J. Membr. Biol. 246(10):723–724, 2013.
Miklavcic, D., D. Semrov, V. Valencic, G. Sersa, and L. Vodovnik. Tumor treatment by direct electric current: computation of electric current and power density distribution. Electro- Magnetobiol. 16(2):119–128, 1991.
Mir, L. M., S. Orlowski, J. J. Belehradek, and C. Paoletti. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer. 27(1):68–72, 1991.
Moir, J., S. A. White, J. J. French, P. Littler, and D. M. Manas. Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer. EJSO. 40:1598–1604, 2014.
Neumann, E., and K. Rosenheck. Permeability changes induced by electric impulses in vesicular membranes. J. Membr. Biol. 29(10):279–290, 1972.
Neumann, E., M. Schaeffer-Ridder, Y. Wang, and P. H. Hofschneider. Gene transfer into mouse lymphoma cells by electroporation in high electric fields. EMBO J. 1(7):841–845, 1982.
Neumann, E., A. E. Sowers, and C. A. Jordan (eds.). Electroporation and Electrofusion in Cell Biology. New York: Plenum Press, 1989.
Olaiz, N., C. Suarez, M. Risk, F. Molina, and G. Marshall. Tracking protein electrodenaturation fronts in the electrochemical treatment of tumors. Electrochem. Commun. 12(1):94–97, 2010.
Phillips, M., N. Raju, L. Rubinsky, and B. Rubinsky. Modulating electrolytic tissue ablation with reversible electroporation pulses. Technology. 3(1):1–9, 2015.
Phillips, M., L. Rubinsky, A. Meir, N. Raju, and B. Rubinsky. Combining electrolysis and electroporation for tissue ablation. Technol. Cancer Res. Treat. 14(4):395–410, 2015.
Rebersek, M., and D. Miklavcic. Advantages and disadvantages of different concepts of electroporation pulse generation. Automatika. 52(1):12–19, 2011.
Rubinsky, L., Guenther, E., Mikus, P., Stehling, M., and Rubinsky, B. Electrolytic effect during tissue ablation by electroporation. Technol. Cancer Res. Treat. 2015 Aug. 31 [Epub].
Rubinsky, B., G. Onik, and P. Mikus. Irreversible electroporation: a new ablation modality—clinical implications. Technol. Cancer Res. Treat. 6(1):37–48, 2007.
Sale, A. J. H., and W. A. Hamilton. Effects of high electric fields on microorganisms. 1. Killing of bacteria and yeasts. Biochimica et Biophysica Acta. 148:781–788, 1967.
Saulis, G., R. Lape, R. Praneviciute, and D. Mickevicius. Changes of the solution pH due to exposure by high-voltage electric pulses. Bioelectrochemistry. 67(1):101–108, 2005.
Sersa, G., T. Jarm, T. Kotnik, A. Coer, M. Podkrajsek, M. Sentjurc, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br. J. Cancer. 98:388–398, 2008.
Teissie, J. Electropermeabilization of the Cell Membrane. In: Electroporation Protocols: Preclinical and Clinical Gene Medicine2nd, edited by S. Li, J. Cutrera, R. Heller, and J. Teisse. New York: Humana Press, 2014, pp. 25–46.
Titomirov, A. V., S. Sukharev, and E. Kistanova. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochimica et Biophysica Acta. 1088(1):131–134, 1991.
Turjanski, P., N. Olaiz, P. Abou-Adal, C. Suarez, M. Risk, and G. Marshall. pH front tracking in the electrochemical treatment (EChT) of tumors: Experiments and simulations. Electrochimica Acta. 54(26):6199–6206, 2009.
Turjanski, P., N. Olaiz, F. Maglietti, S. Michinski, C. Suarez, F. V. Molina, et al. The role of pH fronts in reversible electroporation. PloS One. 6(4):e17303, 2011.
Yarmush, M. L., A. Goldberg, G. Sersa, T. Kotnik, and D. Miklavcic. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu. Rev. Biomed. Eng. 16:295–320, 2014.
Acknowledgments
This project draws from earlier unpublished work by Inter Science GmbH. We also acknowledge the partial financial support from Inter Science GmbH. Inter Science GmbH had no input in the design of the experiments or the analysis of the data.
Conflict of interest
B.R. has a financial interest in Inter Science GmbH.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Michael Gower oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Phillips, M., Krishnan, H., Raju, N. et al. Tissue Ablation by a Synergistic Combination of Electroporation and Electrolysis Delivered by a Single Pulse. Ann Biomed Eng 44, 3144–3154 (2016). https://doi.org/10.1007/s10439-016-1624-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-016-1624-4